Clinical Trial Update: A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update from the GRADE study comparing major glycemia-lowering medications for Type 2 diabetes to evaluate relative effectiveness and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Sitagliptin (sitagliptin)
• liraglutide (liraglutide)
• metformin (metformin)

Snippet

Sponsor: GRADE Study Group | Conditions: Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications | Phase 3 | Status: COMPLETED | Results posted: 2026-02-10